Funding for this research was provided by:
Received: 10 May 2022
Accepted: 16 July 2022
First Online: 9 August 2022
: Ethical approval in Zambia has been obtained from the National Health Research Ethics Board (NHREB) at the University Teaching Hospital (ethical institution of record), the PATH Research Ethics Committee, and the Institutional Review Board at Tulane University. For the Mali trial, ethics review was undertaken by the Comite D’Ethique of the University of Sciences, Techiques and Technologies of Bamako (ethical institution of record) and by the Ethics Committee of the London School of Hygiene and Tropical Medicine. For the trial in Kenya, ethical approval has been obtained from the Kenya Medical Research Institute (KEMRI) Scientific and Ethics Review Unit (SERU), the Liverpool School of Tropical Medicine; the Centers for Disease Control and Prevention IRB is operating on a reliance agreement with the KEMRI SERU (ethical institution of record).
: Not applicable.
: The authors declare that they have no competing interests.